Details

Autor(en) / Beteiligte

• Bieber, Miriam
• Görgülü, Esra
• Schmidt, Daniela
• Zabel, Kirsten
• Etyemez, Semra
• Friedrichs, Benedikt
• Prvulovic, David
• Reif, Andreas
• Oertel, Viola

Titel

Effects of body-oriented yoga: a RCT study for patients with major depressive disorder

Ist Teil von

• European archives of psychiatry and clinical neuroscience, 2021-10, Vol.271 (7), p.1217-1229

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2021

Quelle

EBSCOhost Psychology and Behavioral Sciences Collection

Beschreibungen/Notizen

• The major depressive disorder is one of the most common mental illnesses worldwide. Current treatment standards recommend a combined therapy with medication and psychotherapy. As an additive component and to further improvements in treatment, physical activity such as yoga may be integrated into conventional treatment. This study investigates the impact of a 3-month body-oriented yoga in patients with major depressive disorder (MDD). In total, n  = 83 patients were included. An intervention group received a vigorous Ashtanga-Yoga three times a week. The waiting-list control group obtained a treatment as usual (TAU). As a primary outcome depression scores (Beck Depression Inventory-II (BDI-II), Montgomery Asberg Depression Rating Scale (MADRS)) were tested at three time points. Secondary outcome was the positive and negative affect [Positive and Negative Affect Scale (PANAS)] and remission rates. To analyze the data, multilevel models and effect sizes were conducted. The results showed an improvement in BDI-II scores for both groups over time [ γ  =  −  3.46, t (165) =  − 7.99, p  < 0.001] but not between groups [ γ  = 0.98, t (164) = 1.12, p  = 0.263]. An interaction effect (time x group) occurred for MADRS [ γ  = 2.10, t (164) = 2.10, p  < 0.038]. Positive affects improved over time for both groups [ γ  = 1.65, t (165) = 4.03, p  < 0.001]. Negative affects decreased for all over time [ γ  =  −  1.00, t (165) = − 2.51, p  = 0.013]. There were no significant group differences in PANAS. Post hoc tests revealed a greater symptom reduction within the first 6 weeks for all measurements. The effect sizes for depression scores showed a positive trend. Remission rates indicated a significant improvement in the yoga group (BDI-II: 46.81%, MADRS: 17.02%) compared to the control group (BDI: 33.33%, MADRS: 8.33%). The findings suggest that there is a trendsetting additive effect of Ashtanga-Yoga after 3 months on psychopathology and mood with a greater improvement at the beginning of the intervention. Further research in this field can help to achieve more differentiated results.